Suggested Topics within your search.
Suggested Topics within your search.
- Biochemistry 2
- Chemistry, Clinical 2
- Health and Fitness 2
- methods 2
- Bioinformatics 1
- Bioinstrumentation 1
- Biomedical Technology 1
- Computer simulation 1
- Data processing 1
- Electronic Health Records 1
- Genetic Engineering 1
- Health and Wellbeing 1
- Medical Informatics Applications 1
- Medical informatics 1
- Medical technology 1
- Medical telematics 1
- Microbiology 1
- Molecular biology 1
- Technique 1
- Telemedicine 1
- Therapeutics 1
- pharmacology 1
-
4701
Identification of Clusters in a Population With Obesity Using Machine Learning: Secondary Analysis of The Maastricht Study
Published 2025-02-01“…Data (2971 variables) included demographics, lifestyle, biomedical aspects, advanced phenotyping, and social factors (cohort 2010). …”
Get full text
Article -
4702
Aluminum-Induced Alterations in Purinergic System Parameters of BV-2 Brain Microglial Cells
Published 2021-01-01Get full text
Article -
4703
-
4704
Effects of a periodic intermittent theta burst stimulation in Alzheimer’s disease
Published 2024-02-01Get full text
Article -
4705
PRMT5 promotes ovarian cancer growth through enhancing Warburg effect by methylating ENO1
Published 2023-04-01Get full text
Article -
4706
-
4707
-
4708
-
4709
UltraTimTrack: a Kalman-filter-based algorithm to track muscle fascicles in ultrasound image sequences
Published 2025-01-01Get full text
Article -
4710
Telomere Length Is Associated With Adverse Atrial Remodeling in Patients With Atrial Fibrillation
Published 2025-02-01Get full text
Article -
4711
-
4712
MLL4 regulates postnatal palate growth and midpalatal suture development
Published 2025-01-01Get full text
Article -
4713
Construction and iterative redesign of synXVI a 903 kb synthetic Saccharomyces cerevisiae chromosome
Published 2025-01-01Get full text
Article -
4714
-
4715
-
4716
-
4717
-
4718
-
4719
Utility of 131I-HLX58-Der for the Precision Treatment: Evaluation of a Preclinical Radio-Antibody-Drug-Conjugate Approach in Mouse Models
Published 2025-01-01“…Yi Liu,1– 4,* Xiao Wang,1– 3,5,* Ni Zhang,1– 4,* Simin He,1– 4 Jianping Zhang,1– 4 Xiaoping Xu,1– 4 Shaoli Song1– 4 1Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, 200032, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People’s Republic of China; 3Center for Biomedical Imaging, Fudan University, Shanghai, 200032, People’s Republic of China; 4Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, 200032, People’s Republic of China; 5State Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory & Center for Molecular Imaging and Translational Medicine, School of Public Health, Shenzhen Research Institute of Xiamen University, Xiamen University, Xiamen, 361102, People’s Republic of China*These authors contributed equally to this workCorrespondence: Shaoli Song; Xiaoping Xu, Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, 200032, People’s Republic of China, Email shaoli-song@163.com; xxp0012@ustc.eduPurpose: None of the antibody-drug conjugates (ADCs) targeting Claudin 18.2 (CLDN18.2) have received approval from regulatory authorities due to their limited clinical benefits. …”
Get full text
Article -
4720